MNRO
Monro, Inc.
MNRO trails on the overall score without a compensating advantage in the available component scores.
RIVN
Rivian Automotive, Inc.
RIVN has a slight edge over MNRO overall, supported by lower modeled downside and stronger fundamentals.
MNRO Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| Under pressure | |
| Healthy |
MNRO's balance sheet is currently healthy, and its revenue and profitability are stable, but its cash flow is under pressure.
RIVN Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
RIVN's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
MNRO PE Valuation
MNRO has no meaningful PE right now: it lost money over the past year.
RIVN PE Valuation
RIVN has no meaningful PE right now: it lost money over the past year.
MNRO Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Turning to a loss | |
| Stable | |
| Weakening | |
| Limited | |
| High |
Analysts expect MNRO's earnings and profitability to decline, with its revenue holding steady.
RIVN Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
RIVN has the edge over MNRO on the outlook, with more favorable earnings and revenue expectations.
MNRO Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $0.00 | +$0.69 |
| Q2 2026 | $0.23 | +$0.92 |
| Q1 2026 | $0.03 | +$0.25 |
| Q4 2025 | -$0.49 | -177% |
| Q3 2025 | -$0.69 | -179% |
| Q2 2025 | -$0.69 | -163% |
| Q1 2025 | -$0.22 | -119% |
| Q4 2024 | $0.64 | -41% |
MNRO is still losing money, but far less than before: $0.00 per share over the past year, against $0.69 at its worst in mid-2025.
RIVN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$2.25 | +$0.83 |
| Q2 2026 | -$2.58 | +$0.62 |
| Q1 2026 | -$2.92 | +$0.77 |
| Q4 2025 | -$3.07 | +$1.62 |
| Q3 2025 | -$3.08 | +$2.52 |
| Q2 2025 | -$3.20 | +$2.76 |
| Q1 2025 | -$3.69 | +$2.08 |
| Q4 2024 | -$4.69 | +$1.05 |
RIVN has the edge over MNRO on earnings, with more consistent year-over-year improvement.
MNRO Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $283.6M | -1.8% |
| Q2 2026 | $287.1M | -4.6% |
| Q1 2026 | $273.8M | -7.2% |
| Q4 2025 | $293.4M | -4% |
| Q3 2025 | $288.9M | -4.1% |
| Q2 2025 | $301M | +2.7% |
| Q1 2025 | $295M | -4.9% |
| Q4 2024 | $305.8M | -3.7% |
MNRO's revenue has slid since its 2022 peak: $284M last quarter, down 1.8% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 0.9% | -3.5 points |
| Q2 2026 | 1.3% | +3.3 points |
| Q1 2026 | -1.9% | +6.2 points |
| Q4 2025 | 6.3% | +3.1 points |
| Q3 2025 | 4.4% | 0 points |
| Q2 2025 | -2% | -6.5 points |
| Q1 2025 | -8.1% | -11 points |
| Q4 2024 | 3.3% | -3.5 points |
MNRO has the edge over RIVN on profitability, with a higher operating margin.
RIVN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $2.2B | +38% |
| Q2 2026 | $1.7B | +27% |
| Q1 2026 | $1.4B | +11% |
| Q4 2025 | $1.3B | -26% |
| Q3 2025 | $1.6B | +78% |
| Q2 2025 | $1.3B | +13% |
| Q1 2025 | $1.2B | +3% |
| Q4 2024 | $1.7B | +32% |
RIVN has the edge over MNRO on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -41% | +22 points |
| Q2 2026 | -50% | +35 points |
| Q1 2026 | -64% | -11 points |
| Q4 2025 | -65% | -27 points |
| Q3 2025 | -63% | +71 points |
| Q2 2025 | -86% | +33 points |
| Q1 2025 | -53% | +70 points |
| Q4 2024 | -38% | +82 points |
RIVN's operating margin was −41% last quarter, up 22 points from the same quarter a year ago, near the top of its range since 2021.
MNRO Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $28.8M | +8.2% |
| Q2 2026 | -$37.9M | -$28.6M |
| Q1 2026 | $12.4M | -47% |
| Q4 2025 | $9.1M | +15% |
| Q3 2025 | $26.6M | -54% |
| Q2 2025 | -$9.3M | -156% |
| Q1 2025 | $23.2M | +$35.1M |
| Q4 2024 | $7.9M | -73% |
MNRO has the edge over RIVN on cash generation, producing positive trailing cash flow while its opponent burns cash.
RIVN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1.1B | -$703M |
| Q2 2026 | -$849M | -$451M |
| Q1 2026 | -$1.1B | -$549M |
| Q4 2025 | -$1.1B | -234% |
| Q3 2025 | -$421M | +$732M |
| Q2 2025 | -$398M | +$639M |
| Q1 2025 | -$526M | +$997M |
| Q4 2024 | $856M | +$2.3B |
RIVN has burned cash in almost every quarter: −$4.2B over the past year, against −$489M the year before.
MNRO Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +3.8% | +1.1M shares |
| 1 year | -0.2% | -68K shares |
| 3 years | -3% | -977K shares |
| 5 years | -8% | -2.7M shares |
| Available history | -7.9% | -2.7M shares |
MNRO has the edge over RIVN on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q1 2024 | — |
| Q1 2023 | — |
| Q4 2022 | $25.7M |
| Q3 2022 | $54M |
| Q2 2022 | $17.2M |
RIVN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +9.1% | +121M shares |
| 1 year | +19% | +226M shares |
| 3 years | +52% | +494M shares |
RIVN has 1.4B diluted shares, up 19% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2021 | — |
| Q1 2021 | — |
| Q4 2020 | $6M |
| Q3 2020 | — |
| Q2 2020 | — |
| Q1 2020 | — |
MNRO Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.5x | Healthy |
| Q2 2026 | 1.5x | Healthy |
| Q1 2026 | 1.0x | Healthy |
| Q4 2025 | 1.2x | Healthy |
| Q3 2025 | 1.5x | Healthy |
| Q2 2025 | 1.7x | Healthy |
| Q1 2025 | 1.0x | Very low |
| Q4 2024 | 0.8x | Very low |
MNRO's net debt is about 1.5 years of its operating earnings (EBITDA), about the same as a year ago.
RIVN Net Leverage
RIVN's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
MNRO Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 34.0 | Neutral |
| Stochastic | 5.4 | Oversold |
MNRO's weekly RSI is 34 (neutral) and its Stochastic is 5 (oversold).
RIVN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 41.5 | Neutral |
| Stochastic | 25.6 | Neutral |
RIVN's weekly RSI is 41 (neutral) and its Stochastic is 26 (neutral).
MNRO PE vs Consumer Cyclical Sector
| Metric | MNRO | Sector median | Relative |
|---|---|---|---|
| PE | 58x | 18x | 219% above |
| PE % | 85 | 47 | 38 pts above |
MNRO has no meaningful PE right now: it lost money over the past year.
RIVN PE vs Consumer Cyclical Sector
RIVN has no meaningful PE right now: it lost money over the past year.
MNRO Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $12.7 | 18% below |
| 20 week MA | $13.5 | 23% below |
| 50 week MA | $16.4 | 37% below |
| 100 week MA | $16.8 | 38% below |
| 200 week MA | $25.1 | 59% below |
MNRO is in a downtrend: it's below all five of its weekly moving averages, and 59% below its 200-week average.
RIVN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $13.3 | 3.9% below |
| 20 week MA | $15.1 | 15% below |
| 50 week MA | $15.9 | 19% below |
| 100 week MA | $14.7 | 13% below |
| 200 week MA | $15.1 | 15% below |
RIVN is in a downtrend: it's below all five of its weekly moving averages, and 15% below its 200-week average.
MNRO Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $78.9 | $53.1 | -33% |
| 2021 | $53.1 | $59.2 | +11% |
| 2022 | $59.2 | $45.2 | -24% |
| 2023 | $45.2 | $29.3 | -35% |
| 2024 | $29.3 | $24.8 | -16% |
| 2025 | $24.8 | $20.8 | -16% |
| 2026 YTD | $20.8 | $10.4 | -50% |
MNRO has finished four years in a row lower, and it's down 50% so far in 2026.
RIVN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $130.0 | $96.8 | -25% |
| 2022 | $96.8 | $19.1 | -80% |
| 2023 | $19.1 | $23.5 | +23% |
| 2024 | $23.5 | $13.7 | -42% |
| 2025 | $13.7 | $20.9 | +53% |
| 2026 YTD | $20.9 | $12.8 | -39% |
RIVN has the edge over MNRO on returns for 2026, with the stronger performance.